NF2 and meningioma: We performed a drug screening using human malignant meningioma cell lines IOMM-Lee (NF2 wildtype), CH157-MN (NF2-deficient) (Fig. 2A), and a 20 agent-library encompassing both targeted agents and cytotoxic chemotherapeutics.